FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Yu. M. Lopatin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Schriftenreihe:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Schlagworte:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Online Zugang:https://www.rpcardio.com/jour/article/view/1052
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge